Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · IEX Real-Time Price · USD
39.90
+0.17 (0.43%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Astrana Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2009
Net Income
60.7245.1768.9237.6914.12
Upgrade
Depreciation & Amortization
24.9321.320.6518.3518.28
Upgrade
Share-Based Compensation
22.0416.16.753.381.55
Upgrade
Other Operating Activities
-39.46-0.45-25.98-13.26-20.27
Upgrade
Operating Cash Flow
68.2382.1370.3446.1613.67
Upgrade
Operating Cash Flow Growth
-16.93%16.77%52.36%237.62%-46.37%
Upgrade
Capital Expenditures
-28.53-22.94-19.22-1.11-1.04
Upgrade
Acquisitions
-3.84-12.293.45.15-49.4
Upgrade
Change in Investments
-33.1628.1132.3791.46-130.19
Upgrade
Investing Cash Flow
-65.52-7.1116.5495.49-180.63
Upgrade
Dividends Paid
-62.07-14.03-31.09-51.32-61.72
Upgrade
Share Issuance / Repurchase
-8.67-0.6243.4610.27-3.69
Upgrade
Debt Issued / Paid
75.24-0.83-58.69-9.61234.48
Upgrade
Other Financing Activities
-1.08-4.61-1.42-1.04-5.74
Upgrade
Financing Cash Flow
3.42-20.09-47.75-51.7163.33
Upgrade
Net Cash Flow
6.1354.9339.1389.96-3.63
Upgrade
Free Cash Flow
39.759.1951.1145.0512.63
Upgrade
Free Cash Flow Growth
-32.93%15.80%13.46%256.65%-48.08%
Upgrade
Free Cash Flow Margin
2.86%5.17%6.60%6.56%2.25%
Upgrade
Free Cash Flow Per Share
0.681.040.921.230.36
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).